Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson, +19

New England Journal of Medicine

Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

John Rex, Ben de Pauw, John E. Bennett, +16

Clinical Infectious Diseases

Diagnostic MycologyImmunologyDiagnosisPathologyClinical Mycology +14

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

Andrés Pascual, Thierry Calandra, S. Bolay, +3

Clinical Infectious Diseases

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

David W. Denning, Patricia Ribaud, Nöel Milpied, +6

Clinical Infectious Diseases

Antifungal AgentAntifungal AgentsAcute IaMedicinal FungiAcute Invasive Aspergillosis +5

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

John R. Perfect, Kieren A. Marr, Thomas J. Walsh, +8

Clinical Infectious Diseases

Anti-infective AgentsAntifungal AgentHealth SciencesAntifungal AgentsSalvage Treatment +11

Voriconazole Therapeutic Drug Monitoring

Jeannina A. Smith, Nasia Safdar, V. Knasinski, +4

Antimicrobial Agents and Chemotherapy

Pharmaceutical ScienceDisease ProgressionUnderwent Voriconazole MonitoringPharmacotherapyAdverse Drug Reaction +15

Identification of the Cytochrome P450 Enzymes Involved in the N-Oxidation of Voriconazole

Ruth Hyland, B. C. Jones, Dennis A. Smith

Drug Metabolism and Disposition

Correlation of MIC with Outcome for <i>Candida</i> Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Michael A. Pfaller, Daniel J. Diekema, John Rex, +11

Journal of Clinical Microbiology

Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities

Keith Tan, Nigel Brayshaw, Konrad E. Tomaszewski, +2

The Journal of Clinical Pharmacology

In Vivo Pharmacokinetics and Pharmacodynamics of a New Triazole, Voriconazole, in a Murine Candidiasis Model

David R. Andes, Karen Marchillo, T. Stamstad, +1

Antimicrobial Agents and Chemotherapy